Fidelity Advisor Health Care Fund - Class I (FHCIX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
75.96
+0.23 (0.30%)
Sep 18, 2024, 8:01 PM EDT
20.49% (1Y)
| Fund Assets | 4.82B |
| Expense Ratio | 0.72% |
| Min. Investment | $0.00 |
| Turnover | 47.00% |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Dividend Growth | n/a |
| Payout Frequency | n/a |
| Ex-Dividend Date | n/a |
| Previous Close | 75.73 |
| YTD Return | 13.47% |
| 1-Year Return | 19.90% |
| 5-Year Return | 63.00% |
| 52-Week Low | 57.65 |
| 52-Week High | 76.39 |
| Beta (5Y) | 0.80 |
| Holdings | 105 |
| Inception Date | Aug 30, 1996 |
About FHCIX
The fund normally invests primarily in common stocks. It invests at least 80% of assets in securities of companies principally engaged in the design, manufacture, or sale of products or services used for or in connection with health care or medicine. The fund invests in domestic and foreign issuers. It uses fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions, to select investments.
Fund Family Fidelity
Category Health
Performance Rating Average
Risk Rating Average
Stock Exchange NASDAQ
Ticker Symbol FHCIX
Index S&P 500 TR
Performance
FHCIX had a total return of 19.90% in the past year. Since the fund's inception, the average annual return has been 11.60%, including dividends.
Top 10 Holdings
51.17% of assets| Name | Symbol | Weight |
|---|---|---|
| Boston Scientific Corporation | BSX | 9.49% |
| Eli Lilly and Company | LLY | 8.23% |
| UnitedHealth Group Incorporated | UNH | 7.80% |
| Danaher Corporation | DHR | 6.37% |
| Regeneron Pharmaceuticals, Inc. | REGN | 4.36% |
| Merck & Co., Inc. | MRK | 3.92% |
| The Cigna Group | CI | 3.43% |
| Penumbra, Inc. | PEN | 3.04% |
| Stryker Corporation | SYK | 2.34% |
| Insulet Corporation | PODD | 2.19% |